Explanipedia

Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort Study Open

Paolo A. Muraro, Antonio Zito, Alessio Signori, Maria Pia Sormani, Eleonora Rigoni , et al. · 2025

Objective To compare clinical and radiological outcomes among relapsing multiple sclerosis patients treated with autologous hematopoietic stem cell transplantation (AHSCT), alemtuzumab (ATZ), and ocrelizumab (OCR). Methods From a London (U…

A multiscale assessment of bowel impairment in an Italian multiple sclerosis cohort Open

Eleonora Tavazzi, Antonio Zito, Cristina Montomoli, Niels Bergsland, Elena Colombo , et al. · 2023

The long-COVID-19 in older adults: facts and conjectures Open

Tino Emanuele Poloni, Valentina Medici, Antonio Zito, Arenn F. Carlos · 2022

The coronavirus disease-19 (COVID-19) has greatly affected the overall health of the elderly population through direct biological (infection-related) and indirect psychosocial (quarantine- and isolation-related) effects. Because the severe…

COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context. Open

Maria Pia Sormani, Irene Schiavetti, Luca Carmisciano, Cinzia Cordioli, Massimo Filippi , et al. · 2022

Overall, the MS cohort had a risk of severe events that is twice the risk than the age- and sex-matched Italian population. This excess of risk is mainly explained by the EDSS score and comorbidities, whereas a residual increase of hospita…

Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in Italy Open

Riccardo Giossi, Alessandra Consonni, Valentina Torri Clerici, Antonio Zito, Eleonora Rigoni , et al. · 2021

COVID-19 Severity in Multiple Sclerosis Open

Maria Pia Sormani, Irene Schiavetti, Luca Carmisciano, Cinzia Cordioli, Massimo Filippi , et al. · 2021

Background and Objectives It is unclear how multiple sclerosis (MS) affects the severity of COVID-19. The aim of this study is to compare COVID-19–related outcomes collected in an Italian cohort of patients with MS with the outcomes expect…

The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis Open

Roberto Bergamaschi, Marta Ponzano, Irene Schiavetti, Luca Carmisciano, Cinzia Cordioli , et al. · 2021

Background and purpose Some studies have shown that air pollution, often assessed by thin particulate matter with diameter below 2.5 µg/m 3 (PM2.5), may contribute to severe COVID‐19 courses, as well as play a role in the onset and evoluti…

Vessel wall magnetic resonance imaging in COVID‐19‐associated cryptogenic ischemic stroke Open

Federico Mazzacane, Antonio Zito, Serena Magno, Alessandra Persico, Valentina Mazzoleni , et al. · 2021

Background and purpose Acute ischemic stroke (AIS) is a common complication of coronavirus disease 2019 (COVID‐19), but the underlying biological mechanisms remain unclear. We aimed to describe the prevalence of vessel wall alterations in …

How to forget a “traumatic” experience: a case report of transient global amnesia after nasopharyngeal swab for Coronavirus disease 19 Open

Sabrina Ravaglia, Antonio Zito, Lara Ahmad, Isabella Canavero · 2021

Background Transient global amnesia (TGA) is a clinical syndrome characterized by a temporary short-term memory loss with inability to retain new memories, usually lasting 2 to 8 h. TGA may be related to several medical procedures, includi…

Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients Open

Giulia Mallucci, Antonio Zito, Fausto Baldanti, Matteo Gastaldi, Beatrice Dal Fabbro , et al. · 2021

COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context Open

Maria Pia Sormani, Irene Schiavetti, Luca Carmisciano, Cinzia Cordioli, Massimo Filippi , et al. · 2021

A Rare Syndrome Causing Neurogenic Dysphagia Open

Antonio Zito, Paola Bini, Massimiliano Todisco, Giuseppe Cosentino, Simone Mauramati , et al. · 2020

COVID-19 and Guillain–Barré Syndrome: A Case Report and Review of Literature Open

Antonio Zito, Enrico Alfonsi, Diego Franciotta, Massimiliano Todisco, Matteo Gastaldi , et al. · 2020

During the recent coronavirus disease 2019 (COVID-19) outbreak in Northern Italy, we observed a 57-year-old man developing acute motor-sensory axonal neuropathy, a variant of Guillain-Barré syndrome (GBS), 12 days after severe acute respir…

Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod Open

Giulia Mallucci, Antonio Zito, Beatrice Dal Fabbro, Roberto Bergamaschi · 2020

BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset Open

Marco Puthenparampil, Lisa Federle, Silvia Miante, Antonio Zito, Elisabetta Toffanin , et al. · 2017

Antonio Zito YOU? Author Swipe